Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
Merck
Harvard Business School
Colorcon
Mallinckrodt

Last Updated: June 27, 2022

CLINICAL TRIALS PROFILE FOR ZILRETTA


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Zilretta

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02116972 ↗ Study of FX006 vs Normal Saline in Patients With Osteoarthritis of the Knee Completed Flexion Therapeutics, Inc. Phase 2 2014-04-01 The purpose of this study was to assess the magnitude and duration of pain relief of a single IA injection of 2 doses (16 and 32 mg) of FX006, an extended-release formulation of TCA, relative to normal saline (placebo control).
NCT02357459 ↗ Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee Completed Flexion Therapeutics, Inc. Phase 3 2015-01-01 The purpose of this study was to assess the safety and efficacy of FX006 for the treatment of pain in patients with osteoarthritis of the knee.
NCT02468583 ↗ Proof of Concept Study Comparing FX006 to KenalogĀ®-40 in Patients With Post-Traumatic Osteoarthritis of the Knee Terminated Flexion Therapeutics, Inc. Phase 2 2015-02-01 This study was a double-blind, randomized, parallel group, proof of concept study comparing FX006 to KenalogĀ®-40 (triamcinolone acetonide injectable suspension, USP) in patients with post-traumatic osteoarthritis of the knee.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Zilretta

Condition Name

Condition Name for Zilretta
Intervention Trials
Osteoarthritis of the Knee 4
Osteoarthritis, Knee 4
Knee Osteoarthritis 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Zilretta
Intervention Trials
Osteoarthritis, Knee 11
Osteoarthritis 11
Bursitis 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Zilretta

Trials by Country

Trials by Country for Zilretta
Location Trials
United States 74
Australia 3
Canada 3
Denmark 1
Lithuania 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Zilretta
Location Trials
Pennsylvania 8
California 8
Texas 6
North Carolina 5
Florida 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Zilretta

Clinical Trial Phase

Clinical Trial Phase for Zilretta
Clinical Trial Phase Trials
Phase 4 2
Phase 3 2
Phase 2 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Zilretta
Clinical Trial Phase Trials
Completed 8
Recruiting 4
Terminated 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Zilretta

Sponsor Name

Sponsor Name for Zilretta
Sponsor Trials
Flexion Therapeutics, Inc. 11
Medpace, Inc. 1
The University of Texas Health Science Center, Houston 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Zilretta
Sponsor Trials
Industry 13
Other 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
Harvard Business School
Merck
Moodys
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.